Sarepta Therapeutics shares plunge as gene therapy trial falls short of primary goal By: MarketWatch October 31, 2023 at 07:25 AM EDT Company plans to seek label expansion for Duchenne muscular dystrophy treatment Read More >> Related Stocks: Sarepta Therapeutics
